Navigation Links
Wyeth Declares Common and Preferred Stock Dividends
Date:6/26/2008

MADISON, N.J., June 26 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth (NYSE: WYE) declared dividends on both the Common and Preferred Stock of the Company.

A dividend of twenty-eight cents ($.28) per share on the outstanding shares of Common Stock was declared payable on September 2, 2008 to stockholders of record at the close of business on August 13, 2008.

In addition, a dividend of fifty cents ($.50) per share on the outstanding shares of Preferred Stock was declared payable on October 1, 2008 to stockholders of record at the close of business on September 12, 2008.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
3. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
4. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
5. Wyeth Chairman Robert Essner Announces June 27 Retirement
6. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
7. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
9. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
10. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
11. Wyeth Announces Executive Change in Finance Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... to an early access program for SmartBiome -- a novel metagenomic deep-sequencing ... simultaneous specific enrichment and detection of hundreds of different genes. The selective ...
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... results for the fourth quarter and fiscal year ended September 30, ... , , ... -based life sciences and diagnostics company that develops and commercializes ... Commercial Highlights Achieved revenues of $1.4 million more ...
(Date:12/6/2016)... ... December 06, 2016 , ... Discovering new clues to natural treatments that ... what’s happening in our brains. And searching for keys to our immune systems by ... honored with the 2017 Edith and Peter O’Donnell Awards by The ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... ("GPP") portfolio company, today announced it has acquired the assets of Theorem ... Chiltern International and focuses on clinical trial drug packaging, labeling, storage, reconciliation, ...
Breaking Biology Technology:
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... , Nov. 17, 2016  AIC announces that it has just released a new ... that require high-performance scale-out plus high speed data transfer storage solutions. Photo ... ... ... Setting up a high performance computing ...
Breaking Biology News(10 mins):